Women's Fem Dophilus

RC-14 and GR-1 are registered trademarks of Chr. Hansen A/S.

25+ years of research/clinical studies**

{chart} GR-1/ RC-14 75% Control Group 34%

Martinez, et al. Can J Microbiol 2009;55:133-138

{chart} 25+ YEARS OF GR-1/ RC-14 RESEARCH / CLINICAL STUDIES First Research on GR-1/RC-14 Strains Begin 27 Clinical Studies Published Between 2001 and 2014 Fem-Dophilus Introduced (2006)

Usage: For maintenance, take 1 capsule orally per day, preferably with a meal and a glass of water, and increase to 2 capsules per day as needed or take as directed by your qualified healthcare professional.

Under license from Chr. Hansen A/S and protected by Chr. Hansen A/S patents of the WO 00/35465 patent family, and others.

Keep refrigerated.

Keep out of reach of children.

*These statements have not been evaluated by the Food and Drug Administration. This product is not intended to diagnose, treat, cure or prevent any disease.

Made in Denmark by Chr. Hansen A/S

2015 Jarrow Formulas

05115FEM PROD # 103005

VAGINAL/URINARY TRACT HEALTH*

ORAL PROBIOTIC SUPPLEMENT

Contains: Dairy (casein, in trace amounts).

Contains: Dairy (casein, in trace amounts).

No wheat, no gluten, no soybeans, no egg, no fish/shellfish, no peanuts/tree nuts.

Gluten Free

GR-1/RC-14 and VAGINAL FLORA (also called microbiota)

In one of the randomized clinical trials, 75% of women in the GR-1/RC-14 probiotic group experienced significant improvement in vaginal flora composition, while only 34% of women in the placebo (non-probiotic) group experienced similar improvement.

Superior Nutrition and Formulation

USAGE: For maintenance, take 1 capsule orally per day, preferably with a meal and a glass of water, and increase to 2 capsules per day as needed or take as directed by your qualified healthcare professional. If your healthcare professional recommends taking this product in conjunction with antibiotics, take at least 1-2 hours after taking the medication.

If your healthcare professional recommends taking this product in conjunction with antibiotics, take at least 1-2 hours after taking the medication.

Fem-Dophilus contains two patented and clinically documented probiotic strains, Lactobacillus rhamnosus, GR-1 and Lactobacillus reuteri, RC-14, discovered and developed by Dr. Gregor Reid and Dr. Andrew Bruce at Urex Biotech.

Over 25 years of research supports the oral use of GR-1 and RC-14 to colonize and promote vaginal and urinary tract health.* A special manufacturing process protects the probiotic strains in Fem-Dophilus from stomach acid and enhances probiotic bacterial survival to the lower intestine.*

Jarrow Formulas puts the “PRO” in probiotics

PATENTED STRAINS LACTOBACILLUS RHAMNOSUS, GR-1 and LACTOBACILLUS REUTERI, RC-14

5 Billion viable cells per capsule when kept refrigerated and within Best Used Before Date.